Universe Pharmaceuticals Inc Asset Turnover Ratio (UPC), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Universe Pharmaceuticals Inc  (NASDAQ: UPC)
 

Universe Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Universe Pharmaceuticals Inc asset turnover ratio, the ability of Universe Pharmaceuticals Inc's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.26 in the fourth quarter (Sep 30 2025), yet the ratio remained below the average, as UPC's position remain challenging.

Within sector 125 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from to 2641.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

UPC Asset Turnover Ratio (Sep 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2023)
IV. Quarter
Y / Y Asset Change 14.87 % 206102.56 % 166463.85 % 2902.71 % 144906.59 %
Y / Y Revenue Change 55175.24 % - - - -19.52 %
Asset Turnover Ratio (TTM) 0.26 - - - 0
UPC's Total Ranking # 2641 # # # #
Seq. Asset Change 1.01 % -1 % 0 % 14.87 % 181234.39 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 126
Healthcare Sector # 397
Overall Market # 2641

Asset Turnover Ratio Statistics
High Average Low
0.68 0.56 0.26
(Sep 30 2021)   (Sep 30 2025)




UPC Company Profile • Back to UPC Efficiency Comparisons • Compare UPC Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Verrica Pharmaceuticals Inc   0.70 $ 30.829  Millions$ 44.079  Millions
Alkermes Plc   0.70 $ 1,521.338  Millions$ 2,179.966  Millions
Illumina Inc   0.69 $ 4,288.000  Millions$ 6,187.250  Millions
Select Medical Holdings Corp  0.69 $ 3,933.609  Millions$ 5,682.982  Millions
Neurocrine Biosciences Inc   0.69 $ 2,682.700  Millions$ 3,890.475  Millions
Aspira Women s Health inc   0.69 $ 4.199  Millions$ 6.109  Millions
Harrow Inc   0.68 $ 248.576  Millions$ 365.311  Millions
Quest Diagnostics Inc  0.68 $ 10,850.000  Millions$ 16,029.000  Millions
Resmed Inc   0.68 $ 5,224.571  Millions$ 7,730.490  Millions
Cytosorbents Corporation  0.67 $ 32.211  Millions$ 47.973  Millions
Madrigal Pharmaceuticals Inc   0.67 $ 740.640  Millions$ 1,104.179  Millions
Venus Concept Inc   0.67 $ 42.892  Millions$ 64.088  Millions
Stereotaxis Inc   0.67 $ 29.960  Millions$ 44.797  Millions
Inotiv Inc   0.67 $ 513.024  Millions$ 767.431  Millions
10x Genomics Inc   0.67 $ 639.482  Millions$ 957.340  Millions
Biomerica Inc   0.66 $ 4.884  Millions$ 7.357  Millions
Guardant Health Inc   0.66 $ 902.569  Millions$ 1,359.655  Millions
Waters Corporation  0.66 $ 3,105.638  Millions$ 4,681.503  Millions
Sarepta Therapeutics Inc   0.66 $ 2,413.715  Millions$ 3,650.453  Millions
Mirum Pharmaceuticals Inc   0.66 $ 471.794  Millions$ 717.985  Millions
Transmedics Group Inc   0.65 $ 566.354  Millions$ 869.540  Millions
Neuraxis Inc   0.65 $ 3.362  Millions$ 5.163  Millions
Ss Innovations International Inc  0.65 $ 40.946  Millions$ 62.979  Millions
Zoetis Inc   0.65 $ 9,397.000  Millions$ 14,493.250  Millions
Heron Therapeutics Inc   0.65 $ 153.641  Millions$ 237.485  Millions
Dexcom Inc   0.64 $ 4,515.000  Millions$ 7,015.800  Millions
Align Technology inc   0.64 $ 3,982.367  Millions$ 6,192.517  Millions
U S Physical Therapy Inc  0.64 $ 758.711  Millions$ 1,180.756  Millions
Lifestance Health Group Inc   0.64 $ 1,367.570  Millions$ 2,129.686  Millions
Castle Biosciences Inc   0.64 $ 343.530  Millions$ 535.116  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.